# Impact of Local Tissue Inflammation on Intramyocardial Conduction Pathways Post Percutaneous Valve : Evaluation by Positron Emission Tomography on Exploratory Cohort

Study · id `cardio:ct-nct05308888` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05308888](<https://clinicaltrials.gov/study/NCT05308888>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05308888

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT05308888. Allocation not applicable; no masking; primary purpose diagnostic. Start 2022-11-23 (actual); primary completion 2027-11-23 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Phase 2
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT05308888, source copy `cardio:ctgov-nct05308888-2026-06-09`, retrieved 2026-10-26)
- Started: 2022-11-23 (actual) (ClinicalTrials.gov record NCT05308888, source copy `cardio:ctgov-nct05308888-2026-06-09`, retrieved 2026-10-26)
- Primary completion: 2027-11-23 (anticipated) (ClinicalTrials.gov record NCT05308888, source copy `cardio:ctgov-nct05308888-2026-06-09`, retrieved 2026-10-26)
- Completion: 2028-11-23 (anticipated) (ClinicalTrials.gov record NCT05308888, source copy `cardio:ctgov-nct05308888-2026-06-09`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT05308888, source copy `cardio:ctgov-nct05308888-2026-06-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05308888-2026-06-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Impact of Local Tissue Inflammation on Intramyocardial Conduction Pathways Post Percutaneous Valve : Evaluation by Positron Emission Tomography on Exploratory Cohort
- Acronym: IMPACT
- Condition: Aortic Valve Stenosis
- Intervention (Diagnostic test): 18F-FDG PET-CT
- Lead sponsor: University Hospital, Brest
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: University Hospital, Brest (`cardio:org-university-hospital-brest`)

## Provenance

Content hash: ac7b18dc8622ebd99a88a9879c570255a340cc1fe6922e5af3e924b3d53c87bf
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
